(19)
(11) EP 1 001 962 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.03.2003 Bulletin 2003/10

(45) Mention of the grant of the patent:
13.11.2002 Bulletin 2002/46

(21) Application number: 98924534.5

(22) Date of filing: 25.06.1998
(51) International Patent Classification (IPC)7: C07H 19/01, A61K 31/70
(86) International application number:
PCT/IB9800/988
(87) International publication number:
WO 9900/5156 (04.02.1999 Gazette 1999/05)

(54)

PRODUCTION OF AVERMECTIN COMPOUNDS

HERSTELLUNG VON AVERMECTIN-VERBINDUNGEN

PRODUCTION DE COMPOSES D'AVERMECTINE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 23.07.1997 WO PCT/IB97/00916

(43) Date of publication of application:
24.05.2000 Bulletin 2000/21

(73) Proprietor: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventors:
  • HONDA, Masanori
    Chita-gun, Aichi-ken 470-2393 (JP)
  • KADOI, Hiroshi
    Chita-gun, Aichi-ken 470-2393 (JP)
  • MORITA, Hiromasa
    Chita-gun, Aichi-ken 470-2393 (JP)
  • NAGAKURA, Isao
    Chita-gun, Aichi-ken 470-2393 (JP)

(74) Representative: McMunn, Watson Palmer et al
Pfizer Limited Patents Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)


(56) References cited: : 
EP-A- 0 676 236
 WO-A-95/22552
   
  • M.HONDA ET AL.: "Deprotection of Allyl Groups with Sulfinic Acids and Palladium Catalyst." JOURNAL OF ORGANIC CHEMISTRY., vol. 62, no. 25, 12 December 1997, pages 8932-8936, XP002073924 EASTON US
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).